1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow EC20: new trials by email Literature Review of EC20 trials Research Report on EC20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) EC145, Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®), placebo - Ovarian Cancer | Phase 3 | Terminated | Endocyte | 441 | 2011-04-22 | 2021-09-30 |
Neoplasms (1) · Ovarian Neoplasms (1)
Endocyte (1)
Binh Nguyen, MD (1)